Synthetic lethal interaction with BCL-XL blockade deepens response to cetuximab in patient-derived models of metastatic colorectal cancer. Leto SM, Ferri M, Sassi F, Zanella ER, et al. Clin Cancer Res 2023 Jan 9:CCR-22-2550. doi: 10.1158/1078-0432.CCR-22-2550.

Read + Share

Amedeo Smart

Independent Medical Education